← FDA DRUG APPROVALS

FDA ANDA · ANDA085010

ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN

Sponsor: SOLVAY

APPLICATION
ANDA085010
TYPE
ANDA
ORIGINAL APPROVAL
1976-04-15
LATEST ACTION
1988-08-02
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRINDiscontinued
LEVONORDEFRIN 0.05MG/ML, MEPIVACAINE HYDROCHLORIDE 2% · INJECTABLE · INJECTION

Approval history

1988-08-02Labeling · Supplement 19AP
1976-04-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →